CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath

被引：17

作者：

Bainton, RD ^{[1
]}

Byrne, JL ^{[1
]}

Davy, BJ ^{[1
]}

Russell, NH ^{[1
]}

机构：

[1] City Hosp Nottingham, Nottingham, England

来源：

BLOOD | 2002年 / 100卷 / 10期

关键词：

D O I：

10.1182/blood-2002-08-2398

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3843 / 3844

页数：2

共 5 条

[1] High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution [J].

Chakrabarti, S ;

Mackinnon, S ;

Chopra, R ;

Kottaridis, PD ;

Peggs, K ;

O'Gorman, P ;

Chakraverty, R ;

Marshall, T ;

Osman, H ;

Mahendra, P ;

Craddock, C ;

Waldmann, H ;

Hale, G ;

Fegan, CD ;

Yong, K ;

Goldstone, AH ;

Linch, DC ;

Milligan, DW .

BLOOD, 2002, 99 (12) :4357-4363

[2] Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity [J].

Cull, GM ;

Haynes, AP ;

Byrne, JL ;

Carter, GI ;

Miflin, G ;

Rebello, P ;

Hale, G ;

Waldmann, H ;

Russell, NH .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) :754-760

[3] Quantification of CMV viraemia in a case of transfusion-related graft-versus-host disease associated with purine analogue treatment [J].

Deane, M ;

Gor, D ;

Macmahon, ME ;

Emery, V ;

Griffith, PD ;

Cummins, M ;

Prentice, HG .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (01) :162-164

[4] Pharmacokinetics of CAMPATH-1H in BMT patients [J].

Rebello, P ;

Cwynarski, K ;

Varughese, M ;

Eades, A ;

Apperley, JF ;

Hale, G .

CYTOTHERAPY, 2001, 3 (04) :261-267

[5]

SCHILLING PJ, 1990, NEW ENGL J MED, V323, P833, DOI 10.1056/NEJM199009203231216

← 1 →